bpc 157 fda orange book Key Insights from the PTAB's Updated and Biologic Patent Study The FDA's Orange Book
Description
For anyone dealing with GLP-1 medication side effects , that difference is significant

Several reasons may explain the observation that the mean treatment difference was 12.5% in STEP 1 and 8.7% in SELECT
doi: 10.1159/000192434

10.1016/0092-8674(92)90478-U 166 Leiden Open Variation (n.d.)

Exceeded my expectations

The strongest human clinical evidence is for topical use, including the Leyden 2002 photoaging trial and a 2023 NEEL gel topical study reporting an average 28% increase in skin collagen density at 3 months
